Home NDC 62795-1053 T Relief Arthritis Extra Strength
Product NDC 62795-1053
11-digit product format 627951053
Labeler code 62795
Product ID 62795-1053_a0993276-4a03-484c-ae3d-f0cff7c7a009
Type HUMAN OTC DRUG
Nonproprietary name ARNICA MONTANA, BRYONIA ALBA ROOT, SUS SCROFA CARTILAGE, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA PLACENTA, RHODODENDRON AUREUM LEAF,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SULFUR, and COMFREY ROOT
Dosage form TABLET
Route ORAL
Labeler MediNatura Inc
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2022-04-05
Marketing end 0000-00-00
Substance ARNICA MONTANA; BRYONIA ALBA ROOT; COMFREY ROOT; LEDUM PALUSTRE TWIG; RHODODENDRON AUREUM LEAF; SANGUINARIA CANADENSIS ROOT; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF
Active strength 3 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 62795-1053-2 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 62795-1053-2 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 62795-1053-2 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 62795-1053-2 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 62795-1053-2 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 62795-1053-2 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 62795-1053-2 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 62795-1053-2 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 62795-1053-2 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62795-1053-2 T Relief Arthritis Extra Strength 250 in 1 BOTTLE TABLET 250 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62795-1053 T RELIEF ARTHRITIS EXTRA STRENGTH (ARNICA MONTANA, BRYONIA ALBA ROOT, SUS SCROFA CARTILAGE, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA PLACENTA, RHODODENDRON AUREUM LEAF,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SULFUR, AND COMFREY ROOT) TABLET [MEDINATURA INC] 2 Legacy NDC, 1 package rows 20230928_dbfd6183-a058-4292-ab99-31a60b1dd215.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62795-1053-2 62795105302 250 TABLET in 1 BOTTLE (62795-1053-2) 250 tablet 2022-04-05 0000-00-00 No No Current